ABSA International
ABSA International

Resources with keywords: vaccination



Effect of Influenza Vaccination on Risk of Coronavirus Disease 2019: A Prospective Cohort Study of 46,000 Healthcare Workers (NEW 2/3, Website, Publication)
The Journal of Infectious Diseases
5 January 2022

Kristensen JH, et al.

The present findings indicate that influenza vaccination does not affect the risk of SARS-CoV-2 infection or COVID-19.

Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study (NEW 2/3, Website, Publication)
The Lancet: Infectious Diseases
1 January 2022

Antonelli M, et al.

This study aimed to identify risk factors for post-vaccination SARS-CoV-2 infection and describe the characteristics of post-vaccination illness.

Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review (Website, Publication)
Frontiers in Public Health
23 November 2021

Lui, DT, et. al
Literature review of thyroid dysfunction after SARS-CoV-2 vaccination.

COVID-19 Vaccination and Non–COVID-19 Mortality Risk — Seven Integrated Health Care Organizations, United States, December 14, 2020–July 31, 2021 (NEW 11/2, Website, Publication)
CDC/MMWR
29 October 2021

Xu S, Huang R, Sy LS, et al.

COVID-19 Vaccines for Children and Teens (NEW 11/2, Website, Regulatory)
CDC
The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021 (NEW 11/2, Website, Publication)
CDC/MMWR
5 November 2021

Mbaeyi S, Oliver SE, Collins JP, et al.

Booster Shots and Third Doses for COVID-19 Vaccines: What You Need to Know (NEW 10/6, Website)
Johns Hopkins University Medicine
15 August 2021
What to know about booster shots and third doses of the COVID-19 vaccine (NEW 10/6, Website)
University of Chicago Medicine
15 August 2021
COVID Data Tracker Weekly Review (Archived) (Website, Regulatory)
CDC Archive

May 11, 2023, marked the end of the federal COVID-19 public health emergency (PHE) declaration. This doesn’t mean that COVID-19 is over, but the end of the PHE did initiate a cascade of updates to COVID-19 data collection, reporting, and surveillance. Some surveillance metrics will remain the same, but some will change in terms of reporting frequency, data sources, or availability.

COVID-19 Vaccine Safety in Adolescents Aged 12–17 Years — United States, December 14, 2020–July 16, 2021 (NEW 8/3, Website, Publication)
CDC/MMWR
30 July 2021

Hause AM, Gee J, Baggs J, et al.

Go to Top